In this video, Professors Shen-Yang Lim and Christoph Correll discuss the crucial role of dopamine in both Parkinson’s disease and Schizophrenia.
Learn how dopamine deficiency leads to motor symptoms in Parkinson’s disease and how excessive dopaminergic activity contributes to psychosis in Schizophrenia. The discussion covers the evolution of treatments, including levodopa for Parkinson’s disease, and postsynaptic dopamine blockers for Schizophrenia. The conversation also touches on side effects, and parallels between these two brain disorders.
Related content
Continuous maintenance therapy is associated with a lower risk of relapse than intermittent treatment, supporting ongoing treatment strategies in schizophrenia and related psychotic disorders.
Treatment response tends to be higher during a first episode than during subsequent episodes, emphasizing the importance of early intervention and effective management.
Negative symptoms are a core feature of schizophrenia and can have a profound impact on functioning, social relationships, and quality of life.